Michael Scheld

6.2k total citations · 2 hit papers
18 papers, 4.9k citations indexed

About

Michael Scheld is a scholar working on Oncology, Clinical Biochemistry and Microbiology. According to data from OpenAlex, Michael Scheld has authored 18 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Clinical Biochemistry and 4 papers in Microbiology. Recurrent topics in Michael Scheld's work include Bacterial Identification and Susceptibility Testing (5 papers), Bacterial Infections and Vaccines (4 papers) and Neutropenia and Cancer Infections (3 papers). Michael Scheld is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Bacterial Infections and Vaccines (4 papers) and Neutropenia and Cancer Infections (3 papers). Michael Scheld collaborates with scholars based in United States and Germany. Michael Scheld's co-authors include John S. Bradley, George H. Talbot, David N. Gilbert, John E. Edwards, John Bartlett, Brad Spellberg, Helen W. Boucher, Louis B. Rice, John G. Bartlett and Merle A. Sande and has published in prestigious journals such as Clinical Infectious Diseases, Annals of Neurology and The American Journal of Medicine.

In The Last Decade

Michael Scheld

17 papers receiving 4.7k citations

Hit Papers

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infecti... 2006 2026 2012 2019 2008 2006 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
    2008 3.9k citations Helen W. Boucher, George H. Talbot et al. Clinical Infectious Diseases profile →
  2. Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
    2006 846 citations George H. Talbot, John S. Bradley et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Scheld United States 8 2.5k 1.6k 1.1k 787 781 18 4.9k
John Bartlett United States 16 2.2k 0.9× 1.5k 1.0× 1.0k 0.9× 793 1.0× 1.4k 1.7× 40 6.1k
Wright W. Nichols United States 33 2.3k 0.9× 1.7k 1.1× 1.6k 1.5× 550 0.7× 951 1.2× 85 4.3k
Víctor Lorian United States 23 1.5k 0.6× 1.1k 0.7× 1.4k 1.2× 746 0.9× 1.3k 1.7× 108 5.4k
Lynn L. Silver United States 36 1.7k 0.7× 2.5k 1.6× 1.0k 0.9× 313 0.4× 450 0.6× 73 5.4k
David Payne United States 40 2.0k 0.8× 2.5k 1.6× 1.2k 1.1× 287 0.4× 737 0.9× 112 6.4k
Martin Steinbakk Norway 28 1.5k 0.6× 1.1k 0.7× 569 0.5× 901 1.1× 1.2k 1.5× 69 4.9k
Joyce A. Sutcliffe United States 36 1.8k 0.7× 1.5k 0.9× 1.3k 1.1× 394 0.5× 2.1k 2.7× 68 5.7k
George H. Miller United States 37 2.5k 1.0× 1.7k 1.1× 1.2k 1.0× 179 0.2× 713 0.9× 125 5.5k
Ursula Theuretzbacher Austria 31 1.9k 0.8× 958 0.6× 2.1k 1.9× 795 1.0× 1.6k 2.1× 61 5.4k
Ian Morrissey United Kingdom 32 1.4k 0.5× 743 0.5× 969 0.9× 465 0.6× 1.4k 1.8× 116 3.5k

Countries citing papers authored by Michael Scheld

Since Specialization
Citations

This map shows the geographic impact of Michael Scheld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Scheld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Scheld more than expected).

Fields of papers citing papers by Michael Scheld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Scheld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Scheld. The network helps show where Michael Scheld may publish in the future.

Co-authorship network of co-authors of Michael Scheld

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Scheld. A scholar is included among the top collaborators of Michael Scheld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Scheld. Michael Scheld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gray, Megan, Elizabeth T. Rogawski McQuade, Michael Scheld, & Rebecca Dillingham. (2018). 1022. Rising Rates of Injection Drug Use Associated Infective Endocarditis in Virginia With Missed Opportunities for Injection Drug Use Disorder Treatment Referral: A Retrospective Cohort Study. Open Forum Infectious Diseases. 5(suppl_1). S304–S305. 4 indexed citations
2.
Scheld, Michael, Brian Wispelwey, & Richard D. Pearson. (2016). Clinical Pharmacology of Antibiotics. 2 indexed citations
3.
Colebunders, Robert, Jean‐Pierre Van Geertruyden, Stephen N. Kinoti, et al.. (2012). Design of a cluster randomized trial assessing integrated infectious diseases training and on-site support for midlevel practitioners in Uganda. 16(4). 152–159. 12 indexed citations
4.
Boucher, Helen W., George H. Talbot, John S. Bradley, et al.. (2008). Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clinical Infectious Diseases. 48(1). 1–12. 3906 indexed citations breakdown →
5.
Talbot, George H., John S. Bradley, John E. Edwards, et al.. (2006). Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical Infectious Diseases. 42(5). 657–668. 846 indexed citations breakdown →
6.
Hermentin, Peter, et al.. (2005). Comparative analysis of the activity and content of different streptokinase preparations. European Heart Journal. 26(9). 933–940. 28 indexed citations
7.
Scheld, Michael & Walter T. Hughes. (1990). Empiric Antimicrobial Therapy in the Febrile Granulocytopenic Patient. Infection Control and Hospital Epidemiology. 11(3). 151–156. 2 indexed citations
8.
Scheld, Michael & Walter T. Hughes. (1990). Empiric Antimicrobial Therapy in the Febrile Granulocytopenic Patient. Infection Control and Hospital Epidemiology. 11(3). 151–156. 4 indexed citations
9.
Scheld, Michael. (1987). Morphofunctional alterations of the blood-brain barrier during experimental meningitis. The Pediatric Infectious Disease Journal. 6(12). 1145–1146. 2 indexed citations
10.
Sande, Merle A., Michael Scheld, & George H. McCracken. (1987). Report of a Workshop. The Pediatric Infectious Disease Journal. 6(12). 1143–1144. 18 indexed citations
11.
Sande, Merle A., Michael Scheld, & George H. McCracken. (1987). Report of a Workshop. The Pediatric Infectious Disease Journal. 6(12). 1143–1144. 1 indexed citations
12.
Howard, Matthew A., et al.. (1986). Pharmacokinetics of Intraventricular Vancomycin in Hydrocephalic Rats. Neurosurgery. 18(6). 725–729. 4 indexed citations
13.
Williams, Michael E., et al.. (1985). A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host. The American Journal of Medicine. 79(5). 67–72. 18 indexed citations
14.
Spyker, Daniel A., et al.. (1985). Pharmacokinetics of Multiple-Dose Cefoperazone in Hemodialysis Patients. American Journal of Nephrology. 5(5). 355–360. 4 indexed citations
15.
Freedman, John, et al.. (1984). Eficácia do moxalactam no tratamento de meningites purulentas causadas por Haemophilus infuenzae e Neisseria meningitidis. Memórias do Instituto Oswaldo Cruz. 79(1). 29–35.
16.
Scheld, Michael, et al.. (1981). Leukocyte and bacterial interrelationships in experimental meningitis. Annals of Neurology. 9(4). 328–333. 24 indexed citations
17.
Scheld, Michael, et al.. (1981). A Multivariate Approach to Prognostication in Experimental Bacterial Meningitis. American Journal of Clinical Pathology. 76(4). 442–449. 11 indexed citations
18.
Rückert, Ulrich, et al.. (1979). Ergebnisse nach Carotis-Rekonstruktion. DMW - Deutsche Medizinische Wochenschrift. 104(12). 428–431. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Bartlett Breakdown of academic impact, for papers by Wright W. Nichols Breakdown of academic impact, for papers by Víctor Lorian Breakdown of academic impact, for papers by Lynn L. Silver Breakdown of academic impact, for papers by David Payne Breakdown of academic impact, for papers by Martin Steinbakk Breakdown of academic impact, for papers by Joyce A. Sutcliffe Breakdown of academic impact, for papers by George H. Miller Breakdown of academic impact, for papers by Ursula Theuretzbacher Breakdown of academic impact, for papers by Ian Morrissey
Rankless by CCL
2026